M&A

News

Aptar buys digital health partner Healint

More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well

News

Digital health firms DarioHealth and Twill merge

DarioHealth has bought fellow digital health specialist Twill for $10 million upfront, plus another 10 million in stock worth upwards of $20 million, in a move that combin

News

Gilead to buy liver disease specialist CymaBay for $4.3bn

Gilead Sciences has beefed up its pipeline with an agreement to buy CymaBay Therapeutics and its seladelpar drug for rare liver disease primary biliary cholangitis (PBC),

News

Real Chemistry grows in med comms with Avant buy

Life sciences communications agency Real Chemistry has more than doubled its medical team through the acquisition of Avant Healthcare.

News

Could Novo-Catalent deal face antitrust hurdles?

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities

News

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

Novartis is continuing a streak of pipeline-building deals with an agreement to buy Germany’s MorphoSys in a transaction that values the cancer-focused biotech at €2.7 billion (around

Aptar buys digital health partner Healint

Digital health firms DarioHealth and Twill merge

Gilead to buy liver disease specialist CymaBay for $4.3bn

Real Chemistry grows in med comms with Avant buy

Could Novo-Catalent deal face antitrust hurdles?

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

M&A

Editor's Picks